VICP
Price:
$1.5
Market Cap:
$48.56M
Vicapsys Life Sciences, Inc. focuses on the development and commercialization of VICAPSYN proprietary product. Its product is applied to transplantation therapies and related stem-cell applications in the transplantation field. The company is also developing VYBRIN, a product based on CXCL12 for prevention of post-surgical adhesions in abdominal surgery, coating of implantable medical devices and other implants to eliminate fibrosis, and wound healing with a focus on diabetic ulcers. The company was formerly known as Phage Therapeutics International, Inc. and changed its name to Vicapsys Life Sciences, Inc. in September 2017. Vicapsys Life Sciences, Inc. was incorporated in 1997 and is based...[Read more]
Industry
Biotechnology
IPO Date
1998-02-23
Stock Exchange
OTC
Ticker
VICP
According to Vicapsys Life Sciences, Inc.’s latest financial reports and current stock price. The company's current PE Ratio is -50.00. This represents a change of -30.66% compared to the average of -72.11 of the last 4 quarters.
The mean historical PE Ratio of Vicapsys Life Sciences, Inc. over the last ten years is -14.55. The current -50.00 PE Ratio has changed 34.26% with respect to the historical average. Over the past ten years (40 quarters), VICP's PE Ratio was at its highest in in the March 2021 quarter at 43.54. The PE Ratio was at its lowest in in the December 2009 quarter at -418.93.
Average
-14.55
Median
-5.40
Minimum
-60.69
Maximum
-1.68
Discovering the peaks and valleys of Vicapsys Life Sciences, Inc. PE Ratio, unveiling quarterly and yearly fluctuations to gain insights into the company’s financial performance and market dynamics, offering valuable data for investors and analysts alike.
Maximum Annual Increase = 335.37%
Maximum Annual PE Ratio = -1.68
Minimum Annual Increase = -79.17%
Minimum Annual PE Ratio = -60.69
| Year | PE Ratio | Change |
|---|---|---|
| 2024 | -60.69 | 203.16% |
| 2023 | -20.02 | 157.90% |
| 2022 | -7.76 | -79.17% |
| 2021 | -37.27 | 335.37% |
| 2020 | -8.56 | 182.21% |
| 2019 | -3.03 | 2.70% |
| 2018 | -2.95 | 75.77% |
| 2017 | -1.68 | -7.52% |
| 2009 | -1.82 | 4.15% |
The current PE Ratio of Vicapsys Life Sciences, Inc. (VICP) is less than than its 3-year, less than than its 5-year, and less than than its 10-year historical averages
3-year avg
-29.49
5-year avg
-26.86
10-year avg
-14.55
Vicapsys Life Sciences, Inc.’s PE Ratio is less than Calliditas Therapeutics AB (publ) (-23.95), less than ZIVO Bioscience, Inc. (-4.45), less than Relief Therapeutics Holding AG (-2.06), less than Helix BioPharma Corp. (-2.46), less than Arch Biopartners Inc. (-34.62), less than Amplia Therapeutics Limited (-6.86), less than PsyBio Therapeutics Corp. (-0.00), less than Relief Therapeutics Holding AG (-2.06), less than Oncotelic Therapeutics, Inc. (-24.60), less than Sona Nanotech Inc. (-19.87),
| Company | PE Ratio | Market cap |
|---|---|---|
| -23.95 | $36.83M | |
| -4.45 | $38.50M | |
| -2.06 | $48.32M | |
| -2.46 | $132.13M | |
| -34.62 | $59.85M | |
| -6.86 | $41.56M | |
| -0.00 | $1.27K | |
| -2.06 | $43.86M | |
| -24.60 | $42.62M | |
| -19.87 | $41.92M |
One of the best ways to find valuable stocks to invest in is to build a custom made screener in your Excel or Google Sheets spreadsheet. This allows you to compare thousands of companies like Vicapsys Life Sciences, Inc. using the financials and key metrics that matter to you in a single view.
The easiest way to set this up is to use the Wisesheets add-on and set your spreadsheet like this:
Covering all these metrics from financial, data, dividend data, key metrics and more you can get all the data you want for over 50+ exchanges worldwide.
Get your free trial here.
The easiest way to analyze a company like Vicapsys Life Sciences, Inc. or any others is to create a spreadsheet model that automatically retrieves all of the stock data you need.
Using Wisesheets you can set up a spreadsheet model like this with simple spreadsheet formulas. If you change the ticker you can get all of the data automatically updated for you.
Whether you need live data, historical price data, financials, dividend data, key metrics, analyst estimates, or anything else...Wisesheets has you covered.
What is the PE Ratio?
How can you use the PE Ratio?
What is Vicapsys Life Sciences, Inc.'s PE Ratio?
How is the PE Ratio calculated for Vicapsys Life Sciences, Inc. (VICP)?
What is the highest PE Ratio for Vicapsys Life Sciences, Inc. (VICP)?
What is the 3-year average PE Ratio for Vicapsys Life Sciences, Inc. (VICP)?
What is the 5-year average PE Ratio for Vicapsys Life Sciences, Inc. (VICP)?
How does the current PE Ratio for Vicapsys Life Sciences, Inc. (VICP) compare to its historical average?